BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.53%)
As of: Aug 21, 2026 · 1:21 PM EDT

BeyondSpring (BYSI) Operating Margin Growth (3y) (2024)

BeyondSpring (BYSI) Operating Margin Growth (3y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.41 Bn 131.56 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.14 Bn 78.15 Bn 3.93 Bn -204.00
3 Argenx Se 65.52 Bn 60.34 Bn 1.37 Bn -537.00
4 Moderna 58.21 Bn 53.07 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.15 Bn 37.05 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn 9,003.00
7 BioNTech SE 27.95 Bn 9.56 Bn 668.28 Mn -11,254.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.30 Bn 26.46 Bn - -2,649.00
10 BeyondSpring 29.77 Mn 29.77 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 532,697.00